348 related articles for article (PubMed ID: 20384019)
21. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
[TBL] [Abstract][Full Text] [Related]
23. Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
Jalandhara N; Arora R; Batuman V
Clin Pharmacol Ther; 2011 Jun; 89(6):920-3. PubMed ID: 21471962
[No Abstract] [Full Text] [Related]
24. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
Heinz-Peer G; Neruda A; Watschinger B; Vychytil A; Geusau A; Haumer M; Weber M
Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969
[TBL] [Abstract][Full Text] [Related]
25. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
26. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
Idée JM; Port M; Dencausse A; Lancelot E; Corot C
Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
[TBL] [Abstract][Full Text] [Related]
27. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Jikki PN
J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
[No Abstract] [Full Text] [Related]
28. [Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].
Varela CU; Prieto-Rayo JC
Rev Med Chil; 2014 Dec; 142(12):1565-74. PubMed ID: 25693439
[TBL] [Abstract][Full Text] [Related]
29. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium and systemic fibrosis: guilt by association.
Kay J; Czirják L
Ann Rheum Dis; 2010 Nov; 69(11):1895-7. PubMed ID: 20959325
[No Abstract] [Full Text] [Related]
31. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
Stratta P; Canavese C; Quaglia M; Fenoglio R
Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228
[No Abstract] [Full Text] [Related]
32. Focus on contrast-associated nephrogenic systemic fibrosis.
Partain CL
J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
[No Abstract] [Full Text] [Related]
33. Special issue: nephrogenic systemic fibrosis.
Leiner T; Kucharczyk W
J Magn Reson Imaging; 2009 Dec; 30(6):1233-5. PubMed ID: 19938034
[No Abstract] [Full Text] [Related]
34. Nephrogenic systemic fibrosis.
Bardin T; Richette P
Curr Opin Rheumatol; 2010 Jan; 22(1):54-8. PubMed ID: 19881349
[TBL] [Abstract][Full Text] [Related]
35. Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
Nicholas BA; Vricella GJ; Smith M; Passalacqua M; Gulani V; Ponsky LE
Can J Urol; 2012 Feb; 19(1):6074-80. PubMed ID: 22316507
[TBL] [Abstract][Full Text] [Related]
36. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
[TBL] [Abstract][Full Text] [Related]
37. Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.
Lu CF; Hsiao CH; Tjiu JW
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):339-40. PubMed ID: 18573157
[No Abstract] [Full Text] [Related]
38. Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.
Heverhagen JT; Krombach GA; Gizewski E
Rofo; 2014 Jul; 186(7):661-9. PubMed ID: 24477507
[TBL] [Abstract][Full Text] [Related]
39. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
Abraham JL; Edward M
AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
[No Abstract] [Full Text] [Related]
40. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
van der Molen AJ
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]